Genetic evidence indicates that the tumor suppressors Ink4a/Arf and Trp53 regulate multiple HSC fate decisions (Akala et al., 2008; Liu et al., 2009; Oguro et al., 2006). Here, CDKN2A is linked to neoplasm.